These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 26706111

  • 1. N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.
    Canale V, Kurczab R, Partyka A, Satała G, Słoczyńska K, Kos T, Jastrzębska-Więsek M, Siwek A, Pękala E, Bojarski AJ, Wesołowska A, Popik P, Zajdel P.
    Bioorg Med Chem; 2016 Jan 15; 24(2):130-9. PubMed ID: 26706111
    [Abstract] [Full Text] [Related]

  • 2. Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile.
    Canale V, Partyka A, Kurczab R, Krawczyk M, Kos T, Satała G, Kubica B, Jastrzębska-Więsek M, Wesołowska A, Bojarski AJ, Popik P, Zajdel P.
    Bioorg Med Chem; 2017 May 15; 25(10):2789-2799. PubMed ID: 28391970
    [Abstract] [Full Text] [Related]

  • 3. Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.
    Canale V, Kurczab R, Partyka A, Satała G, Lenda T, Jastrzębska-Więsek M, Wesołowska A, Bojarski AJ, Zajdel P.
    Eur J Med Chem; 2016 Jan 27; 108():334-346. PubMed ID: 26698537
    [Abstract] [Full Text] [Related]

  • 4. Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α1-adrenergic receptor antagonist with uro-selective activity.
    Rak A, Canale V, Marciniec K, Żmudzki P, Kotańska M, Knutelska J, Siwek A, Stachowicz G, Bednarski M, Nowiński L, Zygmunt M, Zajdel P, Sapa J.
    Bioorg Med Chem; 2016 Nov 01; 24(21):5582-5591. PubMed ID: 27658792
    [Abstract] [Full Text] [Related]

  • 5. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P, Marciniec K, Maślankiewicz A, Satała G, Duszyńska B, Bojarski AJ, Partyka A, Jastrzębska-Więsek M, Wróbel D, Wesołowska A, Pawłowski M.
    Bioorg Med Chem; 2012 Feb 15; 20(4):1545-56. PubMed ID: 22277589
    [Abstract] [Full Text] [Related]

  • 6. The impact of the halogen bonding on D2 and 5-HT1A/5-HT7 receptor activity of azinesulfonamides of 4-[(2-ethyl)piperidinyl-1-yl]phenylpiperazines with antipsychotic and antidepressant properties.
    Partyka A, Kurczab R, Canale V, Satała G, Marciniec K, Pasierb A, Jastrzębska-Więsek M, Pawłowski M, Wesołowska A, Bojarski AJ, Zajdel P.
    Bioorg Med Chem; 2017 Jul 15; 25(14):3638-3648. PubMed ID: 28529043
    [Abstract] [Full Text] [Related]

  • 7. Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M, Marcinkowska M, Bucki A, Pawłowski M, Mitka K, Jaśkowska J, Kowalski P, Kazek G, Siwek A, Wasik A, Wesołowska A, Mierzejewski P, Bienkowski P.
    J Med Chem; 2014 Jun 12; 57(11):4543-57. PubMed ID: 24805037
    [Abstract] [Full Text] [Related]

  • 8. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
    Zajdel P, Marciniec K, Maślankiewicz A, Grychowska K, Satała G, Duszyńska B, Lenda T, Siwek A, Nowak G, Partyka A, Wróbel D, Jastrzębska-Więsek M, Bojarski AJ, Wesołowska A, Pawłowski M.
    Eur J Med Chem; 2013 Feb 12; 60():42-50. PubMed ID: 23279866
    [Abstract] [Full Text] [Related]

  • 9. Quinolinesulfonamides of aryloxy-/arylthio-ethyl piperidines: influence of an arylether fragment on 5-HT1A/5-HT7 receptor selectivity.
    Grychowska K, Marciniec K, Canale V, Szymiec M, Glanowski G, Satała G, Maślankiewicz A, Pawłowski M, Bojarski AJ, Zajdel P.
    Arch Pharm (Weinheim); 2013 Mar 12; 346(3):180-8. PubMed ID: 23381952
    [Abstract] [Full Text] [Related]

  • 10. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT₇ receptor antagonists.
    Zajdel P, Kurczab R, Grychowska K, Satała G, Pawłowski M, Bojarski AJ.
    Eur J Med Chem; 2012 Oct 12; 56():348-60. PubMed ID: 22926225
    [Abstract] [Full Text] [Related]

  • 11. Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands.
    Zajdel P, Marciniec K, Maślankiewicz A, Paluchowska MH, Satała G, Partyka A, Jastrzębska-Więsek M, Wróbel D, Wesołowska A, Duszyńska B, Bojarski AJ, Pawłowski M.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6750-9. PubMed ID: 22001327
    [Abstract] [Full Text] [Related]

  • 12. Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties.
    Canale V, Kotańska M, Dziubina A, Stefaniak M, Siwek A, Starowicz G, Marciniec K, Kasza P, Satała G, Duszyńska B, Bantreil X, Lamaty F, Bednarski M, Sapa J, Zajdel P.
    Molecules; 2021 Jun 23; 26(13):. PubMed ID: 34201675
    [Abstract] [Full Text] [Related]

  • 13. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P, Subra G, Verdie P, Gabzdyl E, Bojarski AJ, Duszyńska B, Martinez J, Pawłowski M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4827-31. PubMed ID: 19560916
    [Abstract] [Full Text] [Related]

  • 14. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié MB, Cosi C, Kleven M.
    J Med Chem; 1999 May 06; 42(9):1648-60. PubMed ID: 10229633
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
    Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P.
    J Med Chem; 2012 Nov 08; 55(21):9255-69. PubMed ID: 23006002
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
    Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):109-19. PubMed ID: 17069795
    [Abstract] [Full Text] [Related]

  • 18. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
    Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P.
    Eur J Pharmacol; 2004 Jul 14; 495(2-3):97-102. PubMed ID: 15249157
    [Abstract] [Full Text] [Related]

  • 19. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G, Zagórska A, Bucki A, Kołaczkowski M, Pawłowski M, Satała G, Bojarski AJ, Partyka A, Wesołowska A, Pękala E, Słoczyńska K.
    Arch Pharm (Weinheim); 2015 Apr 14; 348(4):242-53. PubMed ID: 25773907
    [Abstract] [Full Text] [Related]

  • 20. ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.
    Kołaczkowski M, Mierzejewski P, Bieńkowski P, Wesołowska A, Newman-Tancredi A.
    Br J Pharmacol; 2014 Feb 14; 171(4):973-84. PubMed ID: 24199650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.